80 related articles for article (PubMed ID: 1649357)
1. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.
Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG
Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a CD5 positive, immunosuppressive human myeloma cell line.
Scibienski RJ; Paglieroni TG; MacKenzie MR
Leukemia; 1990 Nov; 4(11):775-80. PubMed ID: 1700238
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules.
Pilarski LM; Jensen GS
Hematol Oncol Clin North Am; 1992 Apr; 6(2):297-322. PubMed ID: 1533857
[TBL] [Abstract][Full Text] [Related]
5. An antigenic study of human plasma cells in normal tissue and in myeloma: identification of a novel plasma cell associated antigen.
Nathan PD; Walker L; Hardie D; Richardson P; Khan M; Johnson GD; Ling NR
Clin Exp Immunol; 1986 Jul; 65(1):112-9. PubMed ID: 3024883
[TBL] [Abstract][Full Text] [Related]
6. Lactate dehydrogenase production and release in a newly established human myeloma cell line.
Hatakeyama N; Daibata M; Nemoto Y; Ohtsuki Y; Taguchi H
Am J Hematol; 2001 Apr; 66(4):267-73. PubMed ID: 11279638
[TBL] [Abstract][Full Text] [Related]
7. Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels.
Pilarski LM; Ruether BA; Mant MJ
J Clin Invest; 1985 Jun; 75(6):2024-9. PubMed ID: 2989339
[TBL] [Abstract][Full Text] [Related]
8. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
9. [Establishment and biological characteristics of human multiple myeloma cell line CZ-1].
Hou J; Zhang B; Zhang L; Ding S
Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):509-13. PubMed ID: 12482345
[TBL] [Abstract][Full Text] [Related]
10. The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma.
Waldmann TA; Broder S; Krakauer R; MacDermott RP; Durm M; Goldman C; Meade B
Fed Proc; 1976 Jul; 35(9):2067-72. PubMed ID: 1084293
[TBL] [Abstract][Full Text] [Related]
11. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Mannoji M; Namba M
Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
[TBL] [Abstract][Full Text] [Related]
12. Establishment of Epstein-Barr virus-negative diffuse large cell lymphoma cell line with an 8;22 chromosomal translocation.
Ichinose I; Nakano S; Ohshima K; Mitsugi K; Anzai K; Shida T; Niho Y
Cancer Res; 1991 Oct; 51(19):5392-7. PubMed ID: 1913659
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-transformed B-cell line (DV-1) derived from bone marrow of a patient with severe combined immunodeficiency and immunoblastic lymphoma.
Rosenblatt HM; Lewis DE; Sklar J; Cleary ML; Parikh N; Galili N; Ritz J; Shearer WT
Pediatr Res; 1987 Apr; 21(4):331-7. PubMed ID: 3033590
[TBL] [Abstract][Full Text] [Related]
14. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
[TBL] [Abstract][Full Text] [Related]
15. Immature B cells in fetal development and immunodeficiency: studies of IgM, IgG, IgA and IgD production in vitro using Epstein-Barr virus activation.
Pereira S; Webster D; Platts-Mills T
Eur J Immunol; 1982 Jul; 12(7):540-6. PubMed ID: 6288397
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma: an immunologic profile. IV. The EA rosette-forming cell is a Leu-1 positive immunoregulatory B cell.
MacKenzie MR; Paglieroni TG; Warner NL
J Immunol; 1987 Jul; 139(1):24-8. PubMed ID: 2953812
[TBL] [Abstract][Full Text] [Related]
17. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
Gallart T; Bladé J; MartÃnez-Quesada J; Sierra J; Rozman C; Vives J
Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
[TBL] [Abstract][Full Text] [Related]
18. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin.
Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K
Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285
[TBL] [Abstract][Full Text] [Related]
19. Establishment and biological characteristics of human multiple myeloma cell line CZ-1.
Hou J; Lin FY; Zhang B; Zhang LZ; Ding SQ
Chin Med J (Engl); 2004 Jan; 117(1):115-9. PubMed ID: 14733786
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines.
Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B
Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
